Skip to main content
# Title Department Research Year
111 Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: Synthesis and biological evaluation Department of Pharmaceutical Organic Chemistry 2022
112 Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold 2022
113 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Pharmaceutics 2022
114 Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities Department of Pharmaceutical Organic Chemistry 2022
115 Micellar Thin Layer Chromatography and Computer-Aided Analysis of Empagliflozin, Linagliptin and Metformin HCl Ternary Mixture Department of Pharmaceutical Analytical Chemistry 2022
116 Insight into the inclusion complexation of Fluconazole with Sulfonatocalix[4]naphthalene in aqueous solution, solid-state, and its antimycotic activity Department of Industrial Pharmacy 2022
117 Development of magnetic molecularly imprinted polymers for the extraction of salivary pepsin prior to analysis by a novel HPLC-SEC method Department of Pharmaceutical Analytical Chemistry 2022
118 An innovative dual recognition aptasensor for specific detection of Staphylococcus aureus based on Au/Fe3O4 binary hybrid Department of Pharmaceutical Analytical Chemistry 2022
119 Publics’ Perceptions of Community Pharmacists and Satisfaction with Pharmacy Services in Al-Madinah City, Saudi Arabia: A Cross Sectional Study Department of Clinical Pharmacy 2022
120 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Clinical Pharmacy 2022